| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |